De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit

Critical Care

Volumn 14, Issue 6, 2010, Pages

  Morel, Jérôme ^a   Casoetto, Julie ^a   Jospé, Richard ^a   Aubert, Gérald ^a   Terrana, Raphael ^a   Dumont, Alain ^a   Molliex, Serge ^a   Auboyer, Christian ^a  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CATHETER INFECTION; DE ESCALATION STRATEGY; DISEASE SEVERITY; DRUG SUBSTITUTION; ENDOCARDITIS; HEAD AND NECK INFECTION; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; INTERSTITIAL PNEUMONIA; LUNG EDEMA; MAJOR CLINICAL STUDY; MEDIASTINITIS; MENINGITIS; MYCOSIS; OUTCOME ASSESSMENT; PERITONITIS; PNEUMONIA; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECURRENT INFECTION; RETROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA; AGED; COMPARATIVE STUDY; DISEASE MANAGEMENT; EMPIRICAL RESEARCH; FEMALE; HEALTH; INTENSIVE CARE; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY;

AGED; ANTI-BACTERIAL AGENTS; DISEASE MANAGEMENT; EMPIRICAL RESEARCH; FEMALE; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; RETROSPECTIVE STUDIES; WORLD HEALTH;

EID: 78650166326     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9373     Document Type: Article

References (28)

1. Kollef MH, Micek ST. Strategies to prevent antimicrobial resistance in the intensive care unit. Crit Care Med 2005, 33:1845-1853. 10.1097/01.CCM.0000171849.04952.79, 16096464.
2. Alberti C, Brun-Buisson C, Chevret S, Antonelli M, Goodman SV, Martin C, Moreno R, Ochagavia AR, Palazzo M, Werdan K, Le Gall JR. Systemic inflammatory response and progression to severe sepsis in critically ill infected patients. Am J Respir Crit Care Med 2005, 171:461-468. 10.1164/rccm.200403-324OC, 15531752.
3. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B. Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 2003, 168:165-172. 10.1164/rccm.2201087, 12851245.
4. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999, 115:462-474. 10.1378/chest.115.2.462, 10027448.
5. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596. 10.1097/01.CCM.0000217961.75225.E9, 16625125.
6. Larche J, Azoulay E, Fieux F, Mesnard L, Moreau D, Thiery G, Darmon M, Le Gall JR, Schlemmer B. Improved survival of critically ill cancer patients with septic shock. Intensive Care Med 2003, 29:1688-1695. 10.1007/s00134-003-1957-y, 13680115.
7. Torres A, Aznar R, Gatell JM, Jimenez P, Gonzalez J, Ferrer A, Celis R, Rodriguez-Roisin R. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990, 142:523-528.
8. Niederman MS. De-escalation therapy in ventilator-associated pneumonia. Curr Opin Crit Care 2006, 12:452-457. 10.1097/01.ccx.0000244126.84989.a2, 16943725.
9. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327. 10.1097/01.CCM.0000298158.12101.41, 18158437.
10. Leone M, Garcin F, Bouvenot J, Boyadjev I, Visintini P, Albanese J, Martin C. Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse. Crit Care Med 2007, 35:379-385. quizz 386, 10.1097/01.CCM.0000253404.69418.AA, 17205011.
11. Rello J, Vidaur L, Sandiumenge A, Rodriguez A, Gualis B, Boque C, Diaz E. De-escalation therapy in ventilator-associated pneumonia. Crit Care Med 2004, 32:2183-2190.
12. Soo Hoo GW, Wen YE, Nguyen TV, Goetz MB. Impact of clinical guidelines in the management of severe hospital-acquired pneumonia. Chest 2005, 128:2778-2787. 10.1378/chest.128.4.2778, 16236955.
13. Alvarez-Lerma F, Alvarez B, Luque P, Ruiz F, Dominguez-Roldan JM, Quintana E, Sanz-Rodriguez C. Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study. Crit Care 2006, 10:R78. 10.1186/cc4919, 1550932, 16704742.
14. Hoffken G, Niederman MS. Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002, 122:2183-2196. 10.1378/chest.122.6.2183, 12475862.
15. Kollef MH, Morrow LE, Niederman MS, Leeper KV, Anzueto A, Benz-Scott L, Rodino FJ. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006, 129:1210-1218. 10.1378/chest.129.5.1210, 16685011.
16. Giantsou E, Liratzopoulos N, Efraimidou E, Panopoulou M, Alepopoulou E, Kartali-Ktenidou S, Manolas K. De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate. Intensive Care Med 2007, 33:1533-1540. 10.1007/s00134-007-0619-x, 17549458.
17. Leone M, Bourgoin A, Cambon S, Dubuc M, Albanese J, Martin C. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med 2003, 31:462-467. 10.1097/01.CCM.0000050298.59549.4A, 12576952.
18. Ibrahim EH, Ward S, Sherman G, Schaiff R, Fraser VJ, Kollef MH. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001, 29:1109-1115. 10.1097/00003246-200106000-00003, 11395584.
19. Rello J, Gallego M, Mariscal D, Soñora R, Valles J. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 1997, 156:196-200.
20. Kollef MH. Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front. Clin Infect Dis 2008, 47:S3-13. 10.1086/590061, 18713047.
21. Cainzos M. Review of the guidelines for complicated skin and soft tissue infections and intra-abdominal infections--are they applicable today?. Clin Microbiol Infect 2008, 14(Suppl 6):9-18. 10.1111/j.1469-0691.2008.02123.x, 19040462.
22. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003, 29:530-538.
23. Définitions des infections associées aux soins. , http://www.sante-jeunesse-sports.gouv.fr/IMG/pdf/rapport_vcourte.pdf
24. Leone M, Perrin AS, Granier I, Visintini P, Blasco V, Antonini F, Albanese J, Martin C. A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients. Intensive Care Med 2007, 33:726-729. 10.1007/s00134-007-0534-1, 17294169.
25. Geissler A, Gerbeaux P, Granier I, Blanc P, Facon K, Durand-Gasselin J. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs. Intensive Care Med 2003, 29:49-54.
26. Mentzelopoulos SD, Pratikaki M, Platsouka E, Kraniotaki H, Zervakis D, Koutsoukou A, Nanas S, Paniara O, Roussos C, Giamarellos-Bourboulis E, Routsi C, Zakynthinos SG. Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa. Intensive Care Med 2007, 33:1524-1532. 10.1007/s00134-007-0683-2, 17549457.
27. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009, 302:2323-2329. 10.1001/jama.2009.1754, 19952319.
28. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000, 162:505-511.